Modern humans left Africa over 60,000 years ago in a migration that many believe was responsible for nearly all of the human population that exist outside Africa today. Now, researchers have revealed that men and women weren’t equal partners in that exodus. By tracing variations in the X chromosome and in the non-sex chromosomes,
Full Post: Ancient African exodus mostly involved men
Obese people who don’t have high cholesterol or diabetes might think they’re healthy - despite the extra pounds.
But new Ohio University research suggests that obesity raises levels of the hormone leptin, which can be as big a threat to the cardiovascular system as cholesterol.
Tadeusz Malinski and colleagues have published the first study to directly observe how high levels of leptin can create a cascade of harmful biochemical changes in the body. Leptin, a peptide hormone produced by fat cells, helps regulate body weight by acting on the hypothalamus to suppress appetite and burn stored fat.
But an excess of fat in the body can produce too much of the hormone, which, in turn, can lower levels of bioavailable nitric oxide. Nitric oxide, produced by the endothelial cells, supports healthy cardiovascular function by relaxing blood vessels and maintaining good blood flow, explained Malinski, who has developed special nanosensors that can detect levels of the substance.
In addition, Malinski found that the high levels of leptin stimulate greater production of superoxide. It reacts with nitric oxide to create peroxynitrite, a very toxic molecule that can impact DNA replication and damage endothelial cells in the vascular system.
“The nanosensors provide a more direct method of determining what processes are occurring in the body. Previously, researchers didn’t have a clear idea of how this works,” said Malinski, the Marvin and Ann Dilley White Distinguished Professor of Biomedical Sciences at Ohio University.
The study, which examined the process in single human cells and also obese mice models, was published in a recent issue of the American Journal of Physiology - Heart and Circulatory Physiology .
Though obesity is closely associated with heart failure, scientists haven’t fully understood the relationship, Malinski noted. The new study suggests that increased levels of leptin alone can cause long-term cardiovascular damage similar to hypertension, arthrosclerosis, diabetes and other disorders.
“Now that we know the exact molecules responsible for the damage, we can design a method to mollify the effect of obesity on the cardiovascular system,” Malinski said.
http://www.ohio.edu/
--------------------------------------------------------------------------------------------
Related Posts:
Patients with the skin disease psoriasis appear more likely to have higher levels of leptin (a hormone produced by fat cells that may contribute to obesity and other metabolic abnormalities) than persons without psoriasis, according to a report in the December issue of Archives of Dermatology. Psoriasis is an autoimmune disease that results in a
Full Post: Psoriasis sufferers more likely to have higher levels of leptin
When an obesity drug called Leptin was first discovered by scientists 13 years ago, experts hoped the appetite-suppressing hormone would be a possible cure for obesity. Leptin failed to realise those expectations and it was discovered that overweight people became unresponsive to Leptin very quickly due to the development of resistance in the brain
Full Post: Fat busting drug Leptin could make a comeback
A new study in the January 7th issue of Cell Metabolism, a Cell Press publication, helps to explain why obese people and animals fail to respond to leptin, a hormone produced by fat that signals the brain to stop eating. What’s more, they show that two FDA-approved drugs might restore leptin sensitivity, offering a novel
Full Post: Novel treatment option for obesity
The naturally high levels of leptin in diabetic patients may reduce the effectiveness of drug-eluting stents used to treat heart blockages, but using a chemical that differs from the one commonly used to coat stents could counteract this effect. The work by researchers at Columbia University Medical Center could potentially improve outcomes in diabetics who
Full Post: Cardiac stent patients with diabetes may benefit from drug that counteracts the effects of leptin
Once-promising drugs that were abandoned in the fight against breast cancer still could be effective in obese patients, new research suggests. In laboratory tests, hormones produced by fat cells stimulate breast cancer cells to migrate and invade surrounding tissues, scientists at Emory University School of Medicine found. A class of drugs called epithelial growth factor
Full Post: EGFR inhibitors show promise for obesity --------------------------------------------------------------------------------------------
